1st Quarter - Report

GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$460,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Provided comments to SAMHSA regarding its final rule modifying the regulations at 42 CFR Part 2.

Contacted: Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); White House Office; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); Health Resources & Services Administration (HRSA); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA)

Bills named: H.R. 1628 (115th), S.Con.Res. 3 (115th)

Medicare/Medicaid MMM

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (support). Oppose the continuation of Medicaid Disproportionate Share Hospital (DSH) cuts. Provided comments to CMS on the OPPS final rule addressing payments to off-campus hospital outpatient departments.

Contacted: Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office; Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Drug Enforcement Administration (DEA); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA)

Bills named: H.R. 1628 (115th), S.Con.Res. 3 (115th)

Budget/Appropriations BUD

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (budget reconciliation bill, H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Oppose funding cuts for the NIH included in President Trumps FY 18 budget proposal (America First: A Budget Blueprint to Make America Great Again).

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Homeland Security, Dept of (DHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); White House Office; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Drug Enforcement Administration (DEA)

Bills named: S.Con.Res. 3 (115th), H.R. 1628 (115th)

Pharmacy PHA

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases. Support drug pricing legislation that would promote competition by fast tracking generic drug applications (H.R. 749/S.297).

LobbyistCovered position, as disclosed
JONATHAN COOPER —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
AISLING WARDE ZACCARELLI —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); White House Office; Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS)

Bills named: S. 297 (115th), H.R. 749 (115th)

Immigration IMM

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

LobbyistCovered position, as disclosed
LAURA ALFREDO —
JONATHAN COOPER —
TIM JOHNSON —
KENNETH E RASKE —
DAVID C RICH —

Contacted: Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); White House Office; Homeland Security, Dept of (DHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Affiliated organisations

OrganisationLocation
GNYHA SERVICES, INC. New York, NY, US
GNYHA VENTURES, INC. New York, NY, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.